ORIGINAL_ARTICLE
Platelet-To-Lymphocyte Ratio as a Predictor of No-Reflow after Primary Percutaneous Coronary Intervention in Patients with ST Elevation Myocardial Infarction: A Systematic Review and Meta-Analysis
Introduction: No-reflow increases the complications and mortality rate of primary percutaneous coronary intervention (PCI). Therefore, it is important to identify patients at a higher risk of developing no-reflow. This study aimed to systematically review the prognostic value of the platelet-to-lymphocyte ratio (PLR) to predict no-reflow. Materials and Methods: The databases, such as Pubmed, EMBASE, and Web of Knowledge were searched for the relevant studies. Two authors independently performed data extraction and quality assessment of the included studies. In this meta-analysis, sensitivity and specificity of PLR, as well as the pooled odds ratio were calculated to predict no-reflow and compared with the pooled means of PLR in no-reflow and reflow groups. Results: According to the results obtained from six out of eight studies in this systematic review, there was a significant association between PLR and no-reflow. Moreover, a pooled six-fold increase of no-reflow risk was observed in the high PLR group. Pooled sensitivity and specificity of PLR to predict no-reflow was 65% (CI95%: 61%-69%) and 77% (CI95%: 76%-79%), respectively. The mean pooled of PLR in the no-reflow group was significantly 65.2 (CI95%: 26.7-103.8) units higher than that in the reflow group. Conclusions: The PLR is a significant predictor of no-reflow in STEMI patients subjected to primary PCI which can be used alone or in combination with other markers to identify patients at higher risk of developing no-reflow.
https://jctm.mums.ac.ir/article_13254_b6c13bf54b11fc11044354271077d10f.pdf
2019-06-01
433
441
10.22038/jctm.2019.39393.1219
Platelet-to-lymphocyte ratio
No-reflow
ST Elevation Myocardial Infarction
Prognosis
Meta-analysis
Amin
Saberi
amnsbr@gmail.com
1
Medical student, Mashhad University of Medical Sciences, Mashhad, Iran
AUTHOR
Mehrdad
Gazanchian
gazanchian.m@gmail.com
2
Medical doctor, Mashhad University of Medical Sciences, Mashhad, Iran
AUTHOR
Ramin
Sadeghi
sadeghir@mums.ac.ir
3
Nuclear Medicine Specialist, Nuclear Medicine Research Center, Mashhad University of Medical Sciences, Mashhad, Iran
AUTHOR
Ali
Eshraghi
alesh81036@yahoo.com
4
Cardiologist, Cardiology Department, Imam Reza Hospital, Mashhad University of Medical Sciences. Mashhad, Iran
LEAD_AUTHOR
1. Benjamin EJ, Blaha MJ, Chiuve SE, Cushman M, Das SR, Deo R, et al. Heart Disease and Stroke Statistics-2017 Update: A Report From the American Heart Association. Circulation. 2017;135(10):e146-e603.
1
2. Investigators G. An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction. N Engl j Med. 1993;1993(329):673-82.
2
3. Van De Werf F, Adgey J, Ardissino D, Armstrong PW, Aylward P, Barbash G, et al. Single-bolus tenecteplase compared with front-loaded alteplase in acute myocardial infarction: the ASSENT-2 double-blind randomised trial. Lancet (London, England). 1999;354(9180):716-22.
3
4. Cannon CP, Gibson CM, Lambrew CT, Shoultz DA, Levy D, French WJ, et al. Relationship of symptom-onset-to-balloon time and door-to-balloon time with mortality in patients undergoing angioplasty for acute myocardial infarction. JAMA. 2000;283(22):2941-7.
4
5. Stone GW, Grines CL, Cox DA, Garcia E, Tcheng JE, Griffin JJ, et al. Comparison of angioplasty with stenting, with or without abciximab, in acute myocardial infarction. N Engl J Med. 2002;346(13):957-66.
5
6. Moosavi-Movahedi AA, Golchin AR, Nazari KK, Chamani J, Saboury AA, Bathaie SZ, et al. Microcalorimetry, energetics and binding studies of DNA–dimethyltin dichloride complexes. Thermochim Acta. 2004;414(2):233-41.
6
7. Morishima I, Sone T, Okumura K, Tsuboi H, Kondo J, Mukawa H, et al. Angiographic no-reflow phenomenon as a predictor of adverse long-term outcome in patients treated with percutaneous transluminal coronary angioplasty for first acute myocardial infarction. J Am Coll Cardiol. 2000;36(4):1202-9.
7
8. Jaffe R, Dick A, Strauss BH. Prevention and treatment of microvascular obstruction-related myocardial injury and coronary no-reflow following percutaneous coronary intervention: a systematic approach. JACC Cardiovasc Interv. 2010;3(7):695-704.
8
9. Ndrepepa G, Tiroch K, Keta D, Fusaro M, Seyfarth M, Pache J, et al. Predictive factors and impact of no reflow after primary percutaneous coronary intervention in patients with acute myocardial infarction. Circ Cardiovasc Interv. 2010:CIRCINTERVENTIONS. 109.896225.
9
10. Brosh D, Assali AR, Mager A, Porter A, Hasdai D, Teplitsky I, et al. Effect of no-reflow during primary percutaneous coronary intervention for acute myocardial infarction on six-month mortality. The American journal of cardiology. 2007;99(4):442-5.
10
11. Mueller H, Dyer A, Greenberg M. The thrombolysis in myocardial infarction (TIMI) trial. Phase I findings. N Engl J Med. 1985;312(14):932-6.
11
12. Mehta RH, Harjai KJ, Boura J, Cox D, Stone GW, O'Neill W, et al. Prognostic significance of transient no-reflow during primary percutaneous coronary intervention for ST-elevation acute myocardial infarction. Am J Cardiol. 2003;92(12):1445-7.
12
13. Zolfagharzadeh M, Pirouzi M, Asoodeh A, Saberi MR, Chamani J. A comparison investigation of DNP-binding effects to HSA and HTF by spectroscopic and molecular modeling techniques. J Biomol Struct Dyn. 2014;32(12):1936-52.
13
14. Schwartz BG, Kloner RA. Coronary no reflow. J Mol Cell Cardiol. 2012;52(4):873-82.
14
15. Balta S, Demırkol S, Kucuk U. The platelet lymphocyte ratio may be useful inflammatory indicator in clinical practice. Hemodial Int. 2013;17(4):668-9.
15
16. Moher D, Liberati A, Tetzlaff J, Altman DG. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Annals of internal medicine. 2009;151(4):264-9, w64.
16
17. Altman DG, McShane LM, Sauerbrei W, Taube SE. Reporting Recommendations for Tumor Marker Prognostic Studies (REMARK): Explanation and Elaboration. PLoS Med. 2012;9(5):e1001216.
17
18. Wan X, Wang W, Liu J, Tong T. Estimating the sample mean and standard deviation from the sample size, median, range and/or interquartile range. BMC Medical Research Methodology. 2014;14(1):135.
18
19. Zamora J, Abraira V, Muriel A, Khan K, Coomarasamy A. Meta-DiSc: a software for meta-analysis of test accuracy data. BMC Med Res Methodol. 2006;6(1):31.
19
20. Zhu W, Zeng N, Wang N. Sensitivity, specificity, accuracy, associated confidence interval and ROC analysis with practical SAS implementations.
20
21. Kim KW, Lee J, Choi SH, Huh J, Park SH. Systematic Review and Meta-Analysis of Studies Evaluating Diagnostic Test Accuracy: A Practical Review for Clinical Researchers-Part I. General Guidance and Tips. Korean J Radiol. 2015;16(6):1175-87.
21
22. Collaboration C. Cochrane handbook for systematic reviews of interventions version 5.1. 0. Higgins JPT, Green S (eds). 2011.
22
23. Liberati A, Altman DG, Tetzlaff J, Mulrow C, Gøtzsche PC, Ioannidis JP, et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. PLoS medicine. 2009;6(7):e1000100.
23
24. Amirpour A, Zavar R, Nejad AR. Association between the platelet-to-lymphocyte ratio and the no-reflow phenomenon and thrombolysis in myocardial infarction flow 3 after primary percutaneous coronary intervention in patients with ST-segment elevation myocardial infarction. Iranian Heart Journal. 2017;18(4):12-20.
24
25. Ayça B, Akin F, Okuyan E. Platelet to lymphocyte ratio as a prognostic marker in primary percutaneous coronary intervention. Platelets. 2015;26(8):816.
25
26. Celık T, Balta S, Demır M, Osman Yıldırım A, Kaya MG, Ozturk C, et al. Predictive value of admission red cell distribution width-platelet ratio for no-reflow phenomenon in acute ST segment elevation myocardial infarction undergoing primary percutaneous coronary intervention. Cardiology Journal. 2016;23(1):84-92.
26
27. Kurtul A, Acikgoz SK. Usefulness of Mean Platelet Volume-to-Lymphocyte Ratio for Predicting Angiographic No-Reflow and Short-Term Prognosis After Primary Percutaneous Coronary Intervention in Patients With ST-Segment Elevation Myocardial Infarction. Am J Cardiol. 2017;120(4):534-41.
27
28. Kurtul A, Yarlioglues M, Murat SN, Ergun G, Duran M, Kasapkara HA, et al. Usefulness of the platelet-to-lymphocyte ratio in predicting angiographic reflow after primary percutaneous coronary intervention in patients with acute st-segment elevation myocardial infarction. Am J Cardiol. 2014;114(3):342-7.
28
29. Toprak C, Tabakci MM, Simsek Z, Arslantas U, Durmus HI, Ocal L, et al. Platelet/lymphocyte ratio was associated with impaired myocardial perfusion and both in-hospital and long-term adverse outcome in patients with ST-segment elevation acute myocardial infarction undergoing primary coronary intervention. Postepy w Kardiologii Interwencyjnej. 2015;11(4):288-97.
29
30. Wang Z, Ren L, Liu N, Peng J. Utility of Hematological Parameters in Predicting No-Reflow Phenomenon After Primary Percutaneous Coronary Intervention in Patients With ST-Segment Elevation Myocardial Infarction. Clinical and Applied Thrombosis/Hemostasis. 2018;24(7):1177-83.
30
31. Yildiz A, Yuksel M, Oylumlu M, Polat N, Akyuz A, Acet H, et al. The utility of the platelet-lymphocyte ratio for predicting no reflow in patients with ST-segment elevation myocardial infarction. Clinical and Applied Thrombosis/Hemostasis. 2015;21(3):223-8.
31
32. Berg R, Buhari C. Treating and Preventing No Reflow in the Cardiac Catheterization Laboratory. Curr Cardiol Rev. 2012;8(3):209-14.
32
33. Niccoli G, Burzotta F, Galiuto L, Crea F. Myocardial No-Reflow in Humans. J Am Coll Cardiol. 2009;54(4):281-92.
33
34. Chamani J, Heshmati M. Mechanism for stabilization of the molten globule state of papain by sodium n-alkyl sulfates: spectroscopic and calorimetric approaches. J Colloid Interf Sci. 2008;322(1):119-27.
34
35. Li W, Liu Q, Tang Y. Platelet to lymphocyte ratio in the prediction of adverse outcomes after acute coronary syndrome: a meta-analysis. Sci Rep. 2017;7:40426.
35
36. Hansson GK. Inflammation, atherosclerosis, and coronary artery disease. New England Journal of Medicine. 2005;352(16):1685-95.
36
37. Gawaz M, Langer H, May AE. Platelets in inflammation and atherogenesis. J Clin Investig. 2005;115(12):3378.
37
38. Zouridakis EG, Garcia-Moll X, Kaski JC. Usefulness of the blood lymphocyte count in predicting recurrent instability and death in patients with unstable angina pectoris. Am J Cardiol. 2000;86(4):449-51.
38
39. Sharif-Barfeh Z, Beigoli S, Marouzi S, Rad AS, Asoodeh A, Chamani J. Multi-spectroscopic and HPLC studies of the interaction between estradiol and cyclophosphamide with human serum albumin: binary and ternary systems. J Solution Chem. 2017;46(2):488-504.
39
40. Tanboga IH, Topcu S, Aksakal E, Kalkan K, Sevimli S, Acikel M. Determinants of angiographic thrombus burden in patients with ST-segment elevation myocardial infarction. Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis. 2014;20(7):716-22.
40
41. Liberati A, Altman DG, Tetzlaff J, Mulrow C, Gøtzsche PC, Ioannidis JPA, et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration. BMJ. 2009;339.
41
ORIGINAL_ARTICLE
Evaluation of Pulmonary Function Test in Patients with Amyotrophic lateral sclerosis and its correlation with the symptoms of the disease
Introduction: Amyotrophic lateral sclerosis (ALS) is a neurogenic progressive disease that leads to muscle atrophy. The purpose of this study was to evaluate pulmonary function test (PFT) in patients with ALS and its correlation with ASL symptoms. Materials and Methods: This cross-sectional study was performed on 32 ALS patients at Ghaem Hospital, Mashhad, Iran. All patients filled out a demographic form and underwent body plethysmography to determine forced vital capacity (FVC), forced expiratory volume in 1 sec (FEV1), and FEV1/FVC indexes based on their gender and age. Blood samples were also collected to analyze atrial blood gas (ABG) and the levels of oxygen and carbon dioxide. Finally, the data were analyzed by using SPSS20 software. Results: The mean age of the patients was 61.66±13.6 years. The prevalence of ALS was higher in females than in males. The study of the symptoms of the disease (87.1%) of the patients in the study was motor disorder, (0.31%) swallowing disorder, (48.0%) cough and shortness of breath and (40.0%) speech impairment. The results showed that there was a significant relationship between hypercarbia and night oxygen saturation , which the hypercarbia abundance was higher among patients whose night oxygen saturation was SO2 ˂90. But there was no significant relationship between hypercarbia and hypoxemia with symptoms of the disease.. Other results showed that the FEV1 test with swallowing disorder (P = 0.01) and cough and shortness of breath (P = 0.02) the results of FVC test with swallowing disorder (P = 0.01) and cough and shortness of breath (P = 0.02) and Also, there was a significant relationship between FEV1 / FVC test with swallowing disorder (P = 0.01) and cough and shortness of breath (P = 0.01) so that, With the normalization of the Pulmonary Function Test and the improvement of the patients , the symptoms of the disease also decreased. Conclusions: Overall, the results indicate that early detection of pulmonary involvement in patients with ALS can lead to interventions such as oxygen therapy and reduce symptoms and help improve their quality of life.
https://jctm.mums.ac.ir/article_12722_bac9e057b23c31638be85fb88edb1e3f.pdf
2019-06-01
442
446
10.22038/jctm.2019.38386.1208
Amyotrophic lateral sclerosis
Pulmonary function test
Symptoms
Mahnaz
Mozdourian
mozdorianmh@mums.ac.ir
1
Pulmonologist, Lung Diseases Research Center, Mashhad University of Medical Sciences, Mashhad, Iran
LEAD_AUTHOR
Davood
Attaran
attarand@mums.ac.ir
2
Pulmonologist, Lung Diseases Research Center, Mashhad University of Medical Sciences, Mashhad, Iran
AUTHOR
Zahra
Javid arabshahi
javidz@mums.ac.ir
3
Pulmonologist, Lung Diseases Research Center, Mashhad University of Medical Sciences, Mashhad, Iran
AUTHOR
Yalda
Ravanshad
ravanshady@mums.ac.ir
4
Community Medicine Specialist, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran
AUTHOR
Reza
Boostani
boostanir@mums.ac.ir
5
Neurologist, Department of Neurology Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran
AUTHOR
1. Gruis KL, Lechtzin N. Respiratory therapies for amyotrophic lateral sclerosis: a primer. Muscle Nerve. 2012; 46:313-31.
1
2. van der Gr aaff MM, Sage CA, Caan MW, Akkerman EM, Lavini C, Majoie CB, et al. Upper and extra-motoneuron involvement in early motoneuron disease: a diffusion tensor imaging study. Brain. 2011; 134:1211-28.
2
3.Brooks BR, Miller RG, Swash M, Munsat TL. El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis. Amyotroph Lateral Scler Other Motor Neuron Disord. 2000; 1(5):293-9.
3
4.Moosavi-Movahedi AA, Golchin AR, Nazari KK, Chamani J, Saboury AA, Bathaie SZ, Tangestani-Nejad S. Microcalorimetry, energetics and binding studies of DNA–dimethyltin dichloride complexes. Thermochim Acta. 2004; 414:233-41.
4
5.Haidet-Phillips AM, Hester ME, Miranda CJ, Meyer K, Braun L, Frakes A, et al. Astrocytes from familial and sporadic ALS patients are toxic to motor neurons. Nat Biotechnol. 2011; 29:824-8.
5
6. Noh EJ, Park MI, Park SJ, Moon W, Jung HJ. A case of amyotrophic lateral sclerosis presented as oropharyngeal Dysphagia. J Neurogastroenterol Motil. 2010; 16:319-22.
6
7.Galvin M, Gaffney R, Corr B, Mays I, Hardiman O. From first symptoms to diagnosis of amyotrophic lateral sclerosis: perspectives of an Irish informal caregiver cohort-a thematic analysis. BMJ Open. 2017; 7:e014985.
7
8. Nicholson TT, Smith SB, Siddique T, Sufit R, Ajroud-Driss S, Coleman JM 3rd, et al. Respiratory pattern and tidal volumes differ for pressure support and volume-assured pressure support in amyotrophic lateral sclerosis. Ann Am Thorac Soc. 2017; 14:1139-46.
8
9.Chamani J, Heshmati M. Mechanism for stabilization of the molten globule state of papain by sodium n-alkyl sulfates: spectroscopic and calorimetric approaches. J Colloid Interface Sci. 2008; 322:119-27.
9
10.Tobin K, Gilthorpe MS, Rooney J, Heverin M, Vajda A, Staines A, et al. Age-period-cohort analysis of trends in amyotrophic lateral sclerosis incidence. J Neurol. 2016; 263:1919-26.
10
11. Ingre C, Roos PM, Piehl F, Kamel F, Fang F. Risk factors for amyotrophic lateral sclerosis. Clin Epidemiol. 2015; 7:181-93.
11
12. Mehta J, Kamdar V, Dumesic D. Phenotypic expression of polycystic ovary syndrome in South Asian women. Obstet Gynecol Surv. 2013; 68:228-34.
12
13. Prell T, Ringer TM, Wullenkord K, Garrison P, Gunkel A, Stubendorff B, et al. Assessment of pulmonary function in amyotrophic lateral sclerosis: when can polygraphy help evaluate the need for non-invasive ventilation? J Neurol Neurosurg Psychiatry. 2016; 87:1022-6.
13
14.Zolfagharzadeh M, Pirouzi M, Asoodeh A, Saberi MR, Chamani J. A comparison investigation of DNP-binding effects to HSA and HTF by spectroscopic and molecular modeling techniques? J Biomol Struct Dyn. 2014; 32:1936-1952.
14
15. Jackson CE, Rosenfeld J, Moore DH, Bryan WW, Barohn RJ, Wrench M, et al. A preliminary evaluation of a prospective study of pulmonary function studies and symptoms of hypoventilation in ALS/MND patients. J Neurol Sci. 2001; 191:75-8.
15
16. Radunovic A, Annane D, Rafiq MK, Brassington R, Mustfa N. Mechanical ventilation for amyotrophic lateral sclerosis/motor neuron disease. Cochrane Database Syst Rev. 2017; 10:CD004427.
16
17. Javad Mousavi SA, Zamani B, Shahabi Shahmiri S, Rohani M, Shahidi GA, Mostafapour E, et al. Pulmonary function tests in patients with amyotrophic lateral sclerosis and the association between these tests and survival. Iran J Neurol. 2014; 13:131-7.
17
18. Chandrasoma B, Balfe D, Naik T, Elsayegh A, Lewis M, Mosenifar Z. Pulmonary function in patients with amyotrophic lateral sclerosis at disease onset. Monaldi Arch Chest Dis. 2012; 77:129-33.
18
19. Sanei H, Asoodeh A, Hamedakbari-Tusi S, Chamani J. Multi-spectroscopic investigations of aspirin and colchicine interactions with human hemoglobin: binary and ternary systems. J Solution Chem. 2011; 40:1905-31.
19
20. Perez T. Amyotrophic lateral sclerosis (ALS): evaluation of respiratory function. Rev Neurol (Paris). 2006; 162:4S188-94.
20
21. Traxinger K, Kelly C, Johnson BA, Lyles RH, Glass JD. Prognosis and epidemiology of amyotrophic lateral sclerosis. Neurol Clin Pract. 2013; 3:313-20.
21
ORIGINAL_ARTICLE
A New Method for Removal of Supraglottic Leech Infestation, an Unusual Cause of Hemoptysis.
Foreign bodies in upper airway may have various presentations and be life threatening. Leeches can attach to upper airway and cause serious problems. Herein we report a 55-year-old man with hemoptysis due to attachment of leech and explain our technique for its removal.
https://jctm.mums.ac.ir/article_13255_a3cdbb5a2a8bcfb5353e4db65369e3af.pdf
2019-06-01
447
449
10.22038/jctm.2019.40770.1228
Bronchoscopy
Cryotherapy
Foreign body
Leech
Mohammad Reza
Kasraei
kasraei.mr@gmail.com
1
Pulmonologist, Tehran University of Medical Scienses,Tehran,Iran
AUTHOR
Ehsan
Ramezanian Nik
ehsan.nick@gmail.com
2
Lung Disease Research Center, Mashhad University of Medical Sciences,
Mashhad,Iran
LEAD_AUTHOR
Baharloo F, Veyckemans F, Francis C, Biettlot MP, Rodenstein DO. Tracheobronchial foreign bodies: presentation and management in children and adults. Chest. 1999 May 1;115(5):1357-62.
1
Rahimi-Rad MH, Alizadeh E, Samarei R. Aquatic leech as a rare cause of respiratory distress and hemoptysis. Pneumologia (Bucharest, Romania). 2011;60(2):85-6.
2
Bilgen C, Karci B, Uluöz Ü. A nasopharyngeal mass: leech in the nasopharynx. International journal of pediatric otorhinolaryngology. 2002 May 31;64(1):73-6.
3
Moosavi-Movahedi AA, Golchin AR, Nazari KK, Chamani J, Saboury AA, Bathaie SZ, Tangestani-Nejad S. Microcalorimetry, energetics and binding studies of DNA–dimethyltin dichloride complexes. Thermochimica acta. 2004 May 27;414(2):233-41..
4
Zhang P, Zhang R, Zou J, Zhu T. A rare case report of tracheal leech infestation in a 40-year-old woman. International journal of clinical and experimental medicine. 2014;7(10):3599.
5
Zolfagharzadeh M, Pirouzi M, Asoodeh A, Saberi MR, Chamani J. A comparison investigation of DNP-binding effects to HSA and HTF by spectroscopic and molecular modeling techniques. Journal of Biomolecular Structure and Dynamics. 2014 Dec 2;32(12):1936-52.
6
Litch JA, Bishop RA. Saturated aqueous sodium chloride solution for the removal of leeches. Tropical doctor. 2000;30(2).
7
Askari N, Eshaghian A. Otorrhagia bleeding due to leech bite. Advanced biomedical research. 2012;1.
8
Chamani J, Heshmati M. Mechanism for stabilization of the molten globule state of papain by sodium n-alkyl sulfates: spectroscopic and calorimetric approaches. Journal of colloid and interface science. 2008 Jun 1;322(1):119-27.
9
Stoller JK. Murray & Nadel’s Textbook of Respiratory Medicine. Annals of the American Thoracic Society. 2015 Aug;12(8):1257-8.
10
Sehgal IS, Dhooria S, Behera D, Agarwal R. Use of cryoprobe for removal of a large tracheobronchial foreign body during flexible bronchoscopy. Lung India: official organ of Indian Chest Society. 2016 Sep;33(5):543.
11
12
ORIGINAL_ARTICLE
Cardiac Myxoma Removal and Coronary Artery Bypass Grafting in a Middle-Aged Woman: A Case Report
Cardiac myxoma is usually a benign tumor in the left atrium that accounts for more than 50% of primary cardiac tumors. A 55-year-old female referred to our hospital with chest pain, referred pain to the left hand, and severe dyspnea. Transthoracic Doppler Echocardiography was performed and the results showed a large and mobile left atrial mass without any attachment to the interatrial septum. In addition, the three-vessel disease was detected using angiography. Myxoma was resected followed by coronary artery bypass grafting surgery.
https://jctm.mums.ac.ir/article_13253_dcbb62d3903aa1f414bd722906ff7789.pdf
2019-06-01
450
452
10.22038/jctm.2019.40645.1231
myxoma
Coronary artery bypass grafting
Thromboembolism
Behrouz
Mottahedi
motahedib@mums.ac.ir
1
Cardiovascular Surgeon , Department of Cardiovascular surgery, Faculty of medicine, Mashhad University of Medical Sciences, Mashhad, Iran
AUTHOR
Majid
Ghodsi
ghodsimj962@mums.ac.ir
2
Cardiovascular Surgeon, Faculty of Medicine ,Department Of Cardiovascular Surgery, Faculty Of Medicine, Mashhad University Of Medical Sciences, Mashhad, Iran
AUTHOR
Bita
Zargaran
bita.zargaran@hotmail.com
3
General practitioner, Faculty of Medicine, Islamic Azad University, Mashhad Branch, Mashhad, Iran
AUTHOR
Roghaye
Alavinejad
alavinejadr1@mums.ac.ir
4
Msn in Medical Surgical Nursing Education, Research Assistant of Department of Cardiovascular Surgery, Faculty of Medicine, Mashhad University Of Medical Sciences
AUTHOR
Mahdi
Kahrom
m.kahrom@gmail.com
5
Cardiovascular Surgeon , Department of Cardiovascular surgery, Faculty of medicine, Mashhad University of Medical Sciences, Mashhad, Iran
LEAD_AUTHOR
1. Flint N, Siegel RJ, Bannykh S, Luthringer DJ. Bi-atrial cardiac myxoma with glandular differentiation: a case report with detailed radiologic-pathologic correlation. Eur Heart J Case Rep. 2018; 2:yty045.
1
2. Patel K, Rahul K, Tarsaria M, Malhotra A. Left atrial myxoma following coronary artery bypass grafting with patient coronary arterial grafts: a rarity. Braz J Cardiovasc Surg. 2017; 32:228-30.
2
3. Zolfagharzadeh M, Pirouzi M, Asoodeh A, Saberi MR, Chamani J. A comparison investigation of DNP-binding effects to HSA and HTF by spectroscopic and molecular modeling techniques. J Biomol Struct Dyn. 2014; 32(12):1936-52.
3
4. Shi X, Liu R. Sudden cardiac death in physicians: an alarming problem in China. Anatol J Cardiol. 2018; 19:158.
4
5. Nehaj F, Sokol J, Mokan M, Jankovicova V, Kovar F, Kubaskova M, et al. Outcomes of patients with newly diagnosed cardiac myxoma: a retrospective multicentric study. Biomed Res Int. 2018; 2018:8320793.
5
6. Chamani J, Heshmati M. Mechanism for stabilization of the molten globule state of papain by sodium n-alkyl sulfates: spectroscopic and calorimetric approaches. J Colloid Interface Sci. 2008; 322(1):119-27.
6
7. Gennari M, Rubino M, Andreini D, Polvani G, Agrifoglio M. Huge left atrial myxoma and concomitant silent coronary artery disease in a young man. Open J Cardiovasc Surg. 2017; 8:5-7.
7
8. Moosavi-Movahedi AA, Golchin AR, Nazari KK, Chamani J, Saboury AA, Bathaie SZ, et al. Microcalorimetry, energetics and binding studies of DNA–dimethyltin dichloride complexes. Thermochim Acta. 2004; 414(2):233-41.
8
9. Majidi Tehrani SM, Ghaderi H, Foroughi M, Hekmat M, Monfared MB, Tatari H, et al. Ten-year evaluation of cardiac myxoma in Shahid Modarres Hospital. Tehran Univ Med J. 2014; 72:87-95.
9
10. Echeverria P, Selwyn J, Daily B, Saa J. Rapidly growing left atrial myxoma with pfo and left-to-right shunt presenting with dyspnea. Crit Care Med. 2019; 47:78.
10
11. Stefanou MI, Rath D, Stadler V, Richter H, Hennersdorf F, Lausberg HF, et al. Cardiac myxoma and cerebrovascular events: a retrospective cohort study. Front Neurol. 2018; 9:823.
11
12. Sanei H, Asoodeh A, Hamedakbari-Tusi S, Chamani J. Multi-spectroscopic investigations of aspirin and colchicine interactions with human hemoglobin: binary and ternary systems. J Solution Chem. 2011;40(11):1905-31.
12
13. Ali N, Zeb S. Acute myocardial infarction in a 36-year-old man from embolized left atrial myxoma. Rawal Med J. 2016; 41:125-7.
13
14. Shah IK, Dearani J, Daly RC, Suri RM, Park SJ, Joyce LD, et al. Cardiac myxomas: a 50-year experience with resection and analysis of risk factors for recurrence. Ann Thorac Surg. 2015; 100:495-500.
14
ORIGINAL_ARTICLE
Aortic Pseudo aneurysm 3 Years after Interposition Tube Graft for Acute Dissection of Ascending Aorta
Introduction: Patients with primary acute aortic dissection are at higher risk of complications, including increasing aortic aneurysm diameter, aortic rupture, aortic pseudo aneurysm, and recurrent aortic dissection. Case presentation We presented the case of a recurrent pseudo aneurysm and rupture of the aorta in the distal ascending aorta and proximal arch 3 years after the initial procedure for acute aortic dissection. The patient had bleeding from previous skin incision. In computed tomography angiography, the site of rupture of the aorta and abnormal communication with sternum were confirmed. Conclusion Recurrent aortic dissection is a catastrophic event and has high mortality; however, it is rare and is treated in a short time by redo surgery.
https://jctm.mums.ac.ir/article_13256_e6ad539ab57a65dd713dafc1bff5e2be.pdf
2019-06-01
453
455
10.22038/jctm.2019.40342.1225
Aortic Dissection
Aortic Pseudoaneurysm
Cardiac Surgery
Aliasghar
Moeinipour
moinipoora1@mums.ac.ir
1
Cardiac Surgeon, Department of Cardiac Surgery, Mashhad University of Medical Sciences, Mashhad, Iran.
AUTHOR
Mohammad
Abbassi Teshnisi
abbasim@mums.ac.ir
2
Cardiac Surgeon, Department of Cardiac Surgery, Mashhad University of Medical Sciences, Mashhad, Iran.
AUTHOR
Mohamadreza
Akbari
mra786emam@yahoo.com
3
General Physician, Faculty of medical science, Mashhad University of Medical Sciences, Mashhad, Iran.
AUTHOR
Kayhan
Mizani
mizanik921@mums.ac.ir
4
Student Research Committee, Faculty of medicine, Mashhad University of Medical Sciences, Mashhad, Iran.
AUTHOR
Mahsa
Moallemi
moallemim921@mums.ac.ir
5
Student Research Committee, Faculty of medicine, Mashhad University of Medical Sciences, Mashhad, Iran.
AUTHOR
Omid
Javdanfar
omidjavid37@yahoo.com
6
Resident of Cardiac Surgery, Department of Cardiac Surgery, Faculty of Medical Science, Mashhad University of Medical Sciences, Mashhad, Iran
AUTHOR
Hamid
Hoseinikhah
hoseinikhahh@mums.ac.ir
7
Cardiac Surgeon, Department of Cardiac Surgery, Mashhad University of Medical Sciences, Mashhad, Iran.
LEAD_AUTHOR
van de Laar IM, Oldenburg RA, Pals G, Roos-Hesselink JW, de Graaf BM, Verhagen JM, et al. Mutations in SMAD3 cause a syndromic form of aortic aneurysms and dissections with early-onset osteoarthritis. Nat Genet. 2011; 43:121-6.
1
Aubart M, Gobert D, Aubart-Cohen F, Detaint D, Hanna N, d’Indya H, et al. Early-onset osteoarthritis, Charcot-Marie-Tooth like neuropathy, autoimmune features, multiple arterial aneurysms and dissections: an unrecognized and life threatening condition. PLoS One. 2014; 9:e96387.
2
Moosavi-Movahedi AA, Golchin AR, Nazari KK, Chamani J, Saboury AA, Bathaie SZ, et al. Microcalorimetry, energetics and binding studies of DNA–dimethyltin dichloride complexes. Thermochim Acta. 2004; 414:233-41.
3
Kirsch M, Legras A, Bruzzi M, Louis N. Fate of the distal aorta after surgical repair of acute DeBakey type I aortic dissection: a review. Arch Cardiovasc Dis. 2011; 104:125-30.
4
Halstead JC, Meier M, Etz C, Spielvogel D, Bodian C, Wurm M, et al. The fate of the distal aorta after repair of acute type A aortic dissection. J Thorac Cardiovasc Surg. 2007; 133:127-35.
5
Zierer A, Voeller RK, Hill KE, Kouchoukos NT, Damiano RJ Jr, Moon MR. Aortic enlargement and late reoperation after repair of acute type A aortic dissection. Ann Thorac Surg. 2007; 84:479-86.
6
Zolfagharzadeh M, Pirouzi M, Asoodeh A, Saberi MR, Chamani J. A comparison investigation of DNP-binding effects to HSA and HTF by spectroscopic and molecular modeling techniques. J Biomol Struct Dyn. 2014; 32:1936-52.
7
Kim JB, Kim K, Lindsay ME, MacGillivray T, Isselbacher EM, Cambria RP, et al. Risk of rupture or dissection in descending thoracic aortic aneurysm. Circulation. 2015; 132:1620-9.
8
Ptaszek LM, Kim K, Spooner AE, MacGillivray TE, Cambria RP, Lindsay ME, et al. Marfan syndrome is associated with recurrent dissection of the dissected aorta. Ann Thorac Surg. 2015; 99:1616-23.
9
Rylski B, Bavaria JE, Beyersdorf F, Branchetti E, Desai ND, Milewski RK, et al. Type A aortic dissection in Marfan syndrome: extent of initial surgery determines long-term outcome. Circulation. 2014; 129:1381-6.
10
Isselbacher EM, Bonaca MP, Di Eusanio M, Froehlich J, Bassone E, Sechtem U, et al. Recurrent aortic dissection: observations from the international registry of aortic dissection. Circulation. 2016; 134:1013-24.
11
Schoenhoff FS, Jungi S, Czerny M, Roost E, Reineke D, Matyas G, et al. Acute aortic dissection determines the fate of initially untreated aortic segments in Marfan syndrome. Circulation. 2013; 127:1569-75.
12
Chamani J, Heshmati M. Mechanism for stabilization of the molten globule state of papain by sodium n-alkyl sulfates: spectroscopic and calorimetric approaches. J Colloid Interface Sci. 2008; 322:119-27.
13
Leshnower BG, Chen EP. When and how to replace the aortic root in type A aortic dissection. Ann Cardiothorac Surg. 2016; 5:377-82.
14
Dell'Aquila AM, Concistre G, Gallo A, Pansini S, Piccardo A, Passerone G, et al. Fate of the preserved aortic root after treatment of acute type A aortic dissection: 23-year follow-up. J Thorac Cardiovasc Surg. 2013; 146:1456-60.
15
Halstead JC, Spielvogel D, Meier DM, Rinke S, Bodian C, Malekan R, et al. Composite aortic root replacement in acute type A dissection: time to rethink the indications? Eur J Cardiothorac Surg. 2005; 27:626-32.
16
Lai DT, Miller DC, Mitchell RS, Oyer PE, Moore KA, Robbins RC, et al. Acute type A aortic dissection complicated by aortic regurgitation: composite valve graft versus separate valve graft versus conservative valve repair. J Thorac Cardiovasc Surg. 2003; 126:1978-86.
17
ORIGINAL_ARTICLE
Giant solitary fibrous tumor of pleura
A 60-year-old male presented with dyspnea and chest pain. He was referred with massive bulky mass. A mass in the left lung was observed using chest X-ray (Figures 1). A computed tomography scan of the chest showed a mass on the left lung with complete lung collapse Figures 2 (A, B). The needle biopsy was performed and the case was diagnosed with solitary fibrous tumor. Subsequently, the patient underwent complete resected open thoracotomy. In our case, the mass dimension was 50 × 35 cm weighting 5.600 gr Figures 3 (A,B).
https://jctm.mums.ac.ir/article_13222_ee198394a8e32109240bf31b370f1b86.pdf
2019-06-01
456
457
10.22038/jctm.2019.39634.1222
solitary fibrous tumor
Pleura
Diagnose
Reza
Bagheri
bagherir@mums.ac.ir
1
Thoracic Surgeon, Lung Diseases Research Center, Mashhad University of Medical Sciences, Mashhad, Iran
LEAD_AUTHOR
ORIGINAL_ARTICLE
Extraction of chicken bone swallowing 10th day after ingestion with penetrating the esophageal walls
A 23-year-old male referred with a history of chicken bone swallowing a week ago (Figure 1). Endoscopy was performed at our center and a chicken bone was found penetrating the esophageal walls (Figure 2). The patient was managed successfully using flexible endoscopy and the chicken bone was removed.
https://jctm.mums.ac.ir/article_13221_59b9812e144befb64490ad6c5e5fce30.pdf
2019-06-01
458
459
10.22038/jctm.2019.40772.1229
Foreign Bodies
Esophageal perforation
Endoscopy
Treatment
Reza
Bagheri
bagherir@mums.ac.ir
1
Thoracic Surgeon, Lung Diseases Research Center, Mashhad University of Medical Sciences, Mashhad, Iran
LEAD_AUTHOR
ORIGINAL_ARTICLE
Very large hydatid cyst in the 17-year-old Woman
A 17-year-old female presented with dyspnea, chest pain, and a very large cyst occupying the entire right hemithorax Figure 1(A, B). The patient is under full cyst extending to membrane Figure 2 (A, B).
https://jctm.mums.ac.ir/article_13257_4132ad2bcb76b8724e0b46e63661d499.pdf
2019-06-01
460
461
10.22038/jctm.2019.40773.1230
Hydatid Cyst
Hemithorax
outcomes
Reza
Bagheri
bagherir@mums.ac.ir
1
Thoracic Surgeon, Lung Diseases Research Center, Mashhad University of Medical Sciences, Mashhad, Iran
LEAD_AUTHOR